Tradestie Institutional Equity Comparison Engine

PKB vs PBE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PBE Overall Edge

PBE Captures Institutional Edge (2โ€“0 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Invesco Biotechnology & Genome ETF (PBE) driven by superior Momentum & Technical, Options & Structure. Fundamentally, PKB trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus PBE at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PKB sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro) against PBE sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PKB N/M vs PBE N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner PBE
1Y -8.0% vs +23.9% ยท 52W Pos 2% vs 71%
Options & Structure Winner PBE
UNCLASSIFIED (2nd %ile IV) vs UNCLASSIFIED (<1st %ile IV)
PKB NYSE Arca
Invesco Building & Construction ETF
Institutional Equity
$85.02
-1.72% 1D
Market Cap N/A
1M Return -2.97%
1Y Return -8.02%
Forward P/E N/M
Unified AI Score
44.0 / 100 HOLD
Tech 43.0 Fund 49.0 Flow 50.0 Mom 54.0
PBE NYSE Arca
Invesco Biotechnology & Genome ETF
Institutional Equity
$96.22
-1.7% 1D
Market Cap N/A
1M Return +0.15%
1Y Return +23.93%
Forward P/E N/M
Unified AI Score
53.2 / 100 HOLD
Tech 41.0 Fund 44.0 Flow 50.0 Mom 41.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PKB -8.02% PBE +23.93% Spread: +31.95 pp (PBE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
PKB TTM Op. Margin: N/A PBE TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PKB vs PBE. Trailing 12-month operating profitability (PKB N/A vs PBE N/A) and valuation multiples (PKB N/M vs PBE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PKB (0) vs PBE (3)
Institutional Metric PKB PBE Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 2% ($84โ€“$116) 71% ($76โ€“$105) Stronger Trend PBE
Beta / 30D Volatility Risk Regime 1.32ฮฒ ยท 35% Vol 0.74ฮฒ ยท 28% Vol Lower Realized Risk PBE
Unified Institutional Score Composite Signal 44.0 / 100 (HOLD) 53.2 / 100 (HOLD) Higher Composite PBE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PKB vs PBE Buy Guide
PKB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PKB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PBE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live PBE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PKB nor PBE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.